BackPell Bio-Med Technology , Ltd. Overview
Pell Bio-Med Technology Co., Ltd.

Pell Bio-Med Technology , Ltd. Return on Equity

Pell Bio-Med Technology , Ltd. (6949.TW) has a ROE of -17.54%, above the Healthcare sector average of -75.84%.

Get informed when a big investor buys or sells

+ Follow

ROE

-17.54%

Return on Equity

-17.54%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Pell Bio-Med Technology , Ltd. (6949.TW) FAQ

As of the most recent data, 6949.TW shows a ROE of -17.54%. That is above the Healthcare sector average of -75.84%. Scroll down for historical charts and peer comparison views.

The Healthcare sector average ROE is about -75.84%. Pell Bio-Med Technology , Ltd. is at -17.54%, which is higher that average. That is roughly 76.9% above the sector mean. Use the comparison chart on this page to see how 6949.TW stacks up against individual peers as well.

Check the historical chart to see whether 6949.TW's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Pell Bio-Med Technology , Ltd. with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Pell Bio-Med Technology , Ltd.'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently -17.54%) with ownership activity and broader fundamentals.

The Healthcare average ROE is about -75.84%, while 6949.TW is at -17.54%. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.